Insider Trading History of Skolnick Phil

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Skolnick Phil since 2006. This trader's CIK number is 1358116. At the time of last reporting, Skolnick Phil was the Chief Scientific Officer of Opiant Pharmaceuticals, Inc.. (stock ticker symbol OPNT). Also see all insider trading activities at Opiant Pharmaceuticals, Inc..

Note that in the past Skolnick Phil also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Opiant Pharmaceuticals, Inc. (OPNT) by Skolnick Phil

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 OPNT 0 $0 480 $9,724 0 $0
2022 OPNT 0 $0 2,530 $58,923 0 $0
2020 OPNT 0 $0 10,000 $135,327 10,000 $90,000
2019 OPNT 0 $0 120,000 $1,623,821 120,000 $1,080,000
2018 OPNT 0 $0 14,137 $243,801 14,137 $127,233

Yearly summary of insider trading at Dov Pharmaceutical Inc (DOVP) by Skolnick Phil

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 DOVP 0 $0 5,000 $80,260 0 $0


Insider trading activities at 2 companies by Skolnick Phil:

1. Opiant Pharmaceuticals, Inc. (OPNT)

2. Dov Pharmaceutical Inc (DOVP)

Table 1. Insider trading of Opiant Pharmaceuticals, Inc. (OPNT) by Skolnick Phil

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-01-27 OPNT Sale 480 20.26 9,724
2022-07-14 OPNT Sale 627 11.85 7,429
2022-01-27 OPNT Sale 1,518 26.19 39,756
2022-01-10 OPNT Sale 385 30.49 11,738
2020-01-07 OPNT Sale 5,943 13.48 80,111
2020-01-08 OPNT Sale 2,842 13.46 38,253
2020-01-02 OPNT Option Ex 10,000 9.00 90,000
2020-01-06 OPNT Sale 515 13.80 7,107
2020-01-02 OPNT Sale 700 14.08 9,856
2019-12-05 OPNT Sale 2,057 13.74 28,263
2019-12-06 OPNT Sale 800 13.34 10,672
2019-12-02 OPNT Option Ex 10,000 9.00 90,000
2019-12-02 OPNT Sale 2,565 14.17 36,346
2019-12-03 OPNT Sale 4,578 13.93 63,771
2019-11-01 OPNT Sale 7,201 15.10 108,735
2019-11-01 OPNT Option Ex 10,000 9.00 90,000
2019-11-05 OPNT Sale 2,500 14.89 37,225
2019-11-04 OPNT Sale 299 15.28 4,568
2019-10-01 OPNT Option Ex 10,000 9.00 90,000
2019-10-01 OPNT Sale 7,289 14.79 107,804
2019-10-02 OPNT Sale 1,102 14.57 16,056
2019-10-03 OPNT Sale 1,609 14.27 22,960
2019-09-03 OPNT Sale 7,506 14.08 105,684
2019-09-04 OPNT Sale 2,494 14.37 35,838
2019-09-03 OPNT Option Ex 10,000 9.00 90,000
2019-08-01 OPNT Option Ex 10,000 9.00 90,000
2019-08-01 OPNT Sale 8,442 11.66 98,433
2019-08-02 OPNT Sale 1,558 11.30 17,605
2019-07-01 OPNT Option Ex 10,000 9.00 90,000
2019-07-01 OPNT Sale 7,805 13.20 103,026
2019-07-02 OPNT Sale 2,195 13.16 28,886
2019-06-03 OPNT Sale 8,414 11.72 98,612
2019-06-04 OPNT Sale 1,586 11.63 18,445
2019-06-03 OPNT Option Ex 10,000 9.00 90,000
2019-05-01 OPNT Option Ex 10,000 9.00 90,000
2019-05-01 OPNT Sale 8,559 11.41 97,658
2019-05-02 OPNT Sale 1,441 11.24 16,196
2019-04-02 OPNT Sale 2,007 12.47 25,027
2019-04-01 OPNT Sale 7,993 12.71 101,591
2019-04-01 OPNT Option Ex 10,000 9.00 90,000
2019-03-01 OPNT Sale 10,000 14.96 149,650
2019-03-01 OPNT Option Ex 10,000 9.00 90,000
2019-02-04 OPNT Sale 2,559 15.31 39,178
2019-02-01 OPNT Option Ex 10,000 9.00 90,000
2019-02-01 OPNT Sale 7,441 15.32 113,996
2019-01-04 OPNT Sale 2,232 13.48 30,087
2019-01-02 OPNT Sale 7,768 13.84 107,509
2019-01-02 OPNT Option Ex 10,000 9.00 90,000
2018-12-03 OPNT Option Ex 4,321 9.00 38,889
2018-12-03 OPNT Sale 1,306 15.85 20,700
2018-12-06 OPNT Sale 3,015 16.15 48,692
2018-11-06 OPNT Sale 3,217 16.81 54,077
2018-11-05 OPNT Sale 300 17.33 5,198
2018-11-01 OPNT Sale 1,521 18.14 27,590
2018-11-01 OPNT Option Ex 5,038 9.00 45,342
2018-10-02 OPNT Sale 1,433 17.24 24,704
2018-10-03 OPNT Sale 1,500 19.23 28,837
2018-10-04 OPNT Sale 1,845 18.43 34,003
2018-10-02 OPNT Option Ex 4,778 9.00 43,002

Table 2. Insider trading of Dov Pharmaceutical Inc (DOVP) by Skolnick Phil

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-04-03 DOVP Sale 5,000 16.05 80,260

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Skolnick Phil (Chief Scientific Officer of Opiant Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.